|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discipline of Biological Sciences,3 Faculty of Science and Information Technology,
Discipline of Immunology and Microbiology,4 Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia 2308
| ABSTRACT |
|---|
|
|
|---|
ductuli efferentes, epididymis, estradiol, immunology, male reproductive tract, Wolffian duct
| INTRODUCTION |
|---|
|
|
|---|
Although it is well established that there are barriers to the movement of solute between blood and the lumen of the seminiferous tubules [68], there is evidence that IgG antibodies can enter the rete testis [9, 10]. It has also been shown that IgG can enter from blood into the interductular compartment of the epididymis [11]. However, there are structural barriers to its transport into the lumen [12], and it is not resolved whether, or how much, IgG can enter the ductuli efferentes or ductus epididymidis through the duct mucosa [11, 1315], or whether fluid reabsorption by the ducts will concentrate antibodies that enter the rete testis [16]. IgG has been detected in fluid from the distal end of the ductus epididymidis [17], and the accessory glands probably contribute some IgG to semen [18].
This report describes a study of rats immunized with a nonreproductive antigen, tetanus toxoid, which was used because it is highly immunogenic and its antibodies would not interact with reproductive antigens. Comparisons are made within rats of the specific IgG in fluids sampled from the lumen of the rete testis, proximal ductus epididymidis, distal ductus epididymidis, seminal vesicles, and prostate glands. The sampling sites were chosen in order to distinguish between the functions the of major units of the reproductive system: the ductuli efferentes, ductus epididymidis, and the main accessory glands of reproduction. Determinations of the total protein content in the luminal fluids from the extratesticular ducts are included in this report for direct comparison with the concentration of specific IgG, and because in earlier reports on the rat there is confounding between the roles of the ductuli efferentes and the proximal ductus epididymidis in determining the concentration of intraluminal protein [19, 20]. This study confirms that IgG enters the rete testis [9, 10], and shows that most is reabsorbed mainly by the ductuli efferentes, although some is concentrated in the lumen as a consequence of fluid reabsorption by the ducts. The effect of administering estradiol on the concentration of specific IgG in the extratesticular ducts was examined, because the treatment is known to perturb fluid reabsorption in the ductuli efferentes [21 23] and so may affect the concentration of IgG in the duct system. Importantly, this work showed that the ductus epididymidis must recognize and compensate for a reduced function of the ductuli. Expression of the neonatal Fc receptor (Fcgrt, also known as FcRn) in the reproductive system was also examined in this study because it is recognized to have a role in IgG-mediated immune surveillance in adult epithelium [2433] and so may provide the mechanism for transporting IgG across the reproductive epithelium.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Immunization
Rats were immunized subcutaneously. The primary immunization was with 40 µg of tetanus toxoid (a gift from CSL, Melbourne, Australia) in Freund's complete adjuvant (Sigma Chemical Co., St. Louis, MO), and this was followed 4 and 6 wk later by booster immunizations with 25 µg tetanus toxoid in Freund's incomplete adjuvant. Nonimmunized rats received the adjuvants containing no antigen. Antibody titers of IgG in systemic blood were determined by ELISA to confirm that high titers were achieved in the immunized animals before sampling reproductive fluids.
Administration of Estradiol
For 7 days before collecton of the reproductive fluids, the rats received daily subcutaneous injections of peanut oil (Meadow Lea Foods Ltd., NSW, Australia) containing 12.5% v/v benzyl benzoate (Ajax Chemical Co. Ltd., NSW, Australia) and 0 or 400 mg of 17ß-estradiol 3-benzoate.
Collection of Reproductive Fluids
Collection of luminal fluids from the extratesticular ducts has been described [16]. Samples were collected from the rete testis by micropuncture, fluid leaving the ductuli efferentes was collected into a microcannula in the proximal ductus epididymidis (proximal zone 1a [34]), and fluid from the distal cauda epididymidis was collected by retrograde flushing the duct with water saturated oil. Samples were transferred to 10 µl microcaps (Drummond Scientific Co., Broomall, PA) and centrifuged at 10 000 x g (5°C; 15 min for samples leaving the testis and proximal ductus epididymidis and 30 min for fluid from the cauda epididymidis) to separate sperm from epididymal plasma. The concentration of sperm in the samples was determined using a hemocytometer [16]. Prostatic fluid was collected from the penis during direct electrical stimulation of the ventral prostate glands (Harvard Universal kymograph; Harvard Apparatus IMS Ltd., Edenbridge, Kent, United Kingdom). The glands were freed from supporting tissue and electrodes held on either side. The stimulus was applied at a pulse width of 1 ms and frequency of 30 to 60 cycles s1. The voltage was increased gradually from 0 to 12 volts until a sample was provided. The sample was collected from the penis into a hematocrit tube. Initially, a small amount of fluid was delivered slowly, then fluid was delivered faster (like an ejaculation) to make up a volume of 510 µl. The fluid was slightly opaque and viscous, and contained no contamination from other body fluids. Samples of secretions from the seminal vesicles were collected by micropuncturing the large ducts where the secretions accumulated. The secretions from the accessory glands were centrifuged (15 min at 10 000 x g at 5°C) to remove any particulate matter that may have been present. Samples of the reproductive fluids were diluted in 4 mg ml1 phenylmethylsulfonyl fluoride in borate-buffered saline (BBS: 25 mM sodium borate and 75 mM sodium chloride, pH 8.3) and frozen to 20°C until assays were performed.
Determination of Protein and Tetanus-Toxoid-Specific IgG in Reproductive Fluids
Protein was determined using Coomassie blue [35]. Anti-tetanus-toxoid-specific IgG was determined by ELISPOT assays [36] using a Bio-dot Microfiltration apparatus (Bio-Rad Laboratories Pty. Ptd., Sydney, Australia) to support a rehydrated nitrocellulose membrane (Hypobond C; Bio-Rad). Sample wells were blotted with tetanus toxoid (0.25 mg ml1) in BBS, and control wells were coated with BBS only. The membrane was incubated overnight at 4°C and then washed (7-times) with Tris-buffered saline (TBS, pH 7.5). The membrane was blocked with 1% (w/v) BSA (BSA-TBS) and incubated for 2.5 h at 37°C, washed with TBS-Tween (TBS containing 0.05% v v1Tween-20: Sigma-Aldrich, St Louis. MO). Samples were diluted 2-fold in BSA-TBS-Tween, applied to the membrane in duplicate, and incubated for 2 h at 37°C. Each membrane contained samples of standard serum (pooled serum collected from animals with a high titer of tetanus-toxoid-specific IgG) and reproductive fluid from unimmunized animals as well as the samples to be assayed from the immunized animals. The wells were washed with TBS-Tween, loaded with biotinylated goat anti-rat IgG (0.5 mg ml1 diluted 1:3000 in 1% BSA; Southern Biotechnology Associates Inc., Birmingham, AL) and incubated overnight at 4°C. After washing with TBS-Tween they were incubated in strepavidin-horseradish peroxidase (Amersham, Sydney, Australia) diluted 1:3000 in BSA-TBS-Tween for 2 h at 37°C and washed in TBS-Tween. The membrane was washed in TBS and the color reaction developed for 5 min in a solution containing 10 ml 0.06% w/v diaminobenzadine (Sigma-Aldrich Pty. Ltd., Castle Hill, Australia) in TBS, 1 ml of 3% hydrogen peroxide and 0.1 ml of 3% w/v nickel chloride metal enhancer solution. The reactants were washed away with deionized water and the membrane dried. Volume densities of each immunospot were determined using the analytical software package Multianalyst and a GM 700 Densitometer (Bio-Rad). ELISA units (EU) were assigned to the dilution series of the standard serum (see above) starting with 1000 Elisa Units and decreasing by half for each 2-fold dilution to produce an exponential standard curve for the plot of volume density against EU ml1.
Determination of Fcgrt mRNA by RT-PCR
Reproductive tissues were removed from animals immediately following euthanasia. Samples from the following regions were extracted for PCR, using the reagents and procedures in a commercial kit (Invitrogen, Mulgrave, Victoria, Australia): testis and ductuli efferentes; Zones 1a (initial segment), 2 (distal caput epididymidis), and 6 (cauda epididymidis) of the epididymis [34]; vas deferens; seminal vesicles; and ventral prostate glands. mRNA was extracted by homogenizing (Tissue Tearor; Biospec Products, Bartlesville, OK) at 4°C in 1 ml TRIzol Reagent (Invitrogen). The resulting pellets were resuspended in 100 µl of diethyl pyrocarbonate (DEPC) water and the concentration of mRNA determined from 260/280 nm absorbances using a Biospec Mini Spectrophotometer (Shimadzu, Rydalmere, NSW, Australia).
For reverse transcription, mRNA (200 µg mRNA in 5 µl of DEPC water) was added to 11 µl DEPC water, heated to 65°C for 5 min, then quenched on ice. A mix of 9 µl of the following (from Invitrogen) was added to the mRNA: 1 µl of 10 µM dNTP, 5µl of 5x Reverse Transcriptase buffer, 2 µl of 0.5 mg/ml Random Primers, 0.5µl of 40 U/µl RNase Out, and 0.5 µl of 200 U/µl M-MLV Reverse Transcriptase. The mixture was incubated (37°C for 60 min, then 95°C for 5 min), quenched on ice, then amplified by real-time PCR. The quality of the cDNA was verified before real-time PCR by amplifying the cDNA by conventional PCR using beta-actin primers and separating the product by electrophoresis on a 2% agarose gel.
Real-time PCR reactions were set up in PCR tubes with a final reaction volume of 25 µl using flanking nucleotide primers and Sybergreen with ROX reference dye (Invitrogen). Primer sequences were designed using Primer Express 2.0 software (PE Applied Biosystems Inc., Foster City, CA). The sequences for rat beta-actin primers were: forward 5'CGC CGT TCC GAA ATT GC 3', reverse 5' GCC GCC GGG TTT TAT AGG 3' (Geneworks Pty Ltd, Hindmarsh, SA, Australia). The rat Fcgrt primers were: forward 5' CGC CCG CCA GAT CTT CT 3', reverse 5'CCA CTA CCA CCA GCA ATA AAC CA 3' (Geneworks Pty. Ltd., Hindmarsh, SA, Australia). The relative increase in reporter fluorescent dye emission was monitored in real time during PCR amplification using the sequence detection system and software (ABI PRISM 7000 sequence detection system and software; PE Applied Biosystems). Each 25 µl reaction volume contained 2 µl of cDNA, 0.5 µl of sense and antisense primers, 0.25 µl of 100X Sybergreen dye, and 12.5 µl of Platinum qPCR supermix-UDG containing ROX reference dye (Invitrogen). Beta-actin RNA was used as an internal standard to control for variability in amplification because of differences in initial RNA concentrations. The level of the Fcgrt RNA relative to beta-actin RNA was calculated using the following formula: relative RNA expression = 2(Ct of FcRn Ct of beta-actin) x 1010, where Ct is on the threshold cycle value [37]. Because the level of Fcgrt RNA was considerably lower than the level of beta-actin RNA, all values were arbitrarily multiplied by 1010 [37].
Calculation of Parameters
Daily sperm production (DSP; sperm day1) was calculated as:
![]() |
Fluid output from the testis (TFO; µl h1) was calculated as
![]() |
The net rate of fluid reabsorbed by the ductuli efferentes (RRT-1a; µl h1) was calculated as
![]() |
The percentage of fluid reabsorbed between the efferent ducts and cauda epididymidis (% R1a-CE) was calculated as
![]() |
The rate of flow of fluid at the distal cauda epididymidis (FCE; µl h1) was estimated as
![]() |
![]() |
![]() |
Experimental Design and Analyses
Comparisons between samples of the reproductive fluids were made within animals. Differences between means were determined by analyses of variance after transforming absolute values to logs and proportions to angles. The variance between treatments and sampling sites was partitioned into individual degrees of freedom using polynomial coefficients. The standard errors shown in the figures and tables are from the variance between animals calculated from untransformed data.
| RESULTS |
|---|
|
|
|---|
Figure 1 shows that administration of estradiol had no effect on mean testis mass, but reduced the mass of the seminal vesicles. It also reduced estimates of daily sperm production (from 28.33 ± 3.28 x 106 sperm day1 testis1 for untreated animals to 18.34 ± 4.54 x 106 sperm day1 testis1 for the treated group; P < 0.05; n = 9). Table 1 shows that the mean concentration of sperm was about the same in samples of fluid from the rete testis of untreated and treated rats. The concentration of sperm increased along the extratesticular duct system because of net reabsorption of 99% of the fluid leaving the testis. However, the reabsorption occurred in different parts of the duct system of untreated and estradiol-treated rats. Whereas the efferent ducts reabsorbed 96% of the fluid leaving the testis of untreated rats, they only reabsorbed 86% in estradiol-treated rats (P < 0.001). This resulted in the rate of flow of fluid into the cannula in the proximal ductus epididyidis of estradiol-treated rats being more than 1.8-fold higher than that of untreated rats. However, there was compensation by the ductus epididymidis for the reduced reabsorption by the ductuli efferentes of estradiol-treated rats. The ductus reabsorbed more fluid in estradiol-treated (90%) than in untreated rats (66%, P < 0.001) resulting in the mean concentration of sperm in the distal ductus epididymidis being much the same for both groups.
|
|
Secretion and Reabsorption of Protein
Table 2 shows that the mean concentrations of protein in fluid leaving the testis of untreated and treated rats was only 1.4% and 1.6% of the concentrations in blood (50.4 ± 7.0 µg µl1 and 63.0 ± 2.8 µg µl1 respectively). The concentration increased more than 2.5-fold in the efferent ducts (P < 0.001) even though there was a net reabsorption of 6878% of the protein entering the ductuli. Although there was not a significant difference in the rates of protein reabsorption in the untreated and estradiol-treated groups, the concentration of protein in the proximal epididymis was greater in the former (P < 0.05). This is probably because more fluid was reabsorbed in the efferent ducts of this group. Protein was secreted into the ductus epididymidis of both untreated and estradiol-treated rats (P < 0.01).
|
Anti-Tetanus-Toxoid-Specific IgG in Reproductive Fluids
The mean titers of anti-tetanus-toxoid-specific IgG in rete testis fluid were much the same for untreated and estradiol-treated rats (Table 3) and only 0.6% and 0.9% of the titers in blood (17 639 x 105 ± 7 260 x 105 EU ml1 and 11 319 x 105 ± 1372 x 105 EU ml1 respectively). Also, there was no significant effect of estradiol treatment on titers of IgG in luminal fluids from the proximal and distal ductus epididymidis. Because of an increase in titers of about 1.5-fold in the ductuli efferentes and 1.5-fold in the ductus epididymidis, the titers of IgG in the distal ductus epididymidis were 1.4% and 2.0% of the titers in blood serum for the untreated and treated rats respectively. The difference in rates of flow of IgG into and net reabsorption from the ductus epididymidis in treated compared with untreated rats (Table 3) reflects the effect of treatment on the rate of fluid reabsorption (described above) by the efferent ducts and ductus epididymidis, and differences in the fluid output from the testis (which did not reach statistical significance).
|
There was no significant effect of the estradiol treatment on the titers of tetanus-toxoid-specific IgG in fluids collected from the prostate glands or seminal vesicles of rats. The mean titers were much the same for fluid from each type of gland (Table 4), and significantly lower (P < 0.05) than the titers of samples from the rete testis and ductus epididymidis (Table 3).
|
Fcgrt mRNA in Reproductive Tract
Figure 2 shows that there was little expression of Fcgrt in the testis and low expression in the accessory glands of reproduction. In the extratesticular ducts there was strong expression in the ductuli efferentes, but the expression varied in the derivatives of the mesonephric duct. In the ductus epididymidis, there was no expression in Zone 1a (initial segment proper), strong expression in Zone 2 (caput epididymidis) and no expression in Zone 6 (cauda epididymidis). There was only low expression in the vas deferens.
|
| DISCUSSION |
|---|
|
|
|---|
The finding in this study that the administration of estradiol reduces fluid reabsorption by the ductuli efferentes is consistent with our earlier work [21]. The effect is dramatic, approximately doubling the flow of fluid into the cannula in the proximal ductus epididymidis. The effect is also consistent among animals. The finding is not obviously consistent with work on the Esr1 knockout mouse [22] or the effects of an ESR1 antiestrogen in the mouse [42] or rat [43]. However, the methodology of the studies is quite different, and the response to estradiol administration that is described in our work may be because systemic estrogen can reduce expression of Esr1 [43], or its effect may be via Esr2 and not Esr1 [43], or via an effect on androgen regulation (because the estradiol treatment did reduce daily sperm production and the mass to the seminal vesicles: see Results and [21]).
A major finding of this study is that the ductuli efferentes and ductus epididymidis work in tandem in regulating the concentration of sperm in the lumen of the extratesticular ducts. This study confirmed that the ductuli reabsorb 96% of the fluid leaving the testis of untreated rats [16]. However, it also showed that when this reabsorption was reduced by estradiol treatment, the ductus epididymidis fully compensated for the increased flow that it received by increasing fluid reabsorption and delivering sperm to the distal ductus epididymidis at the same concentration as in untreated rats.
Our finding that estrogen treatment does not affect the concentration of sperm in the distal cauda epididymidis does not directly disagree with earlier work on the rat [44] and mouse [45] that showed that estrogen administration increased the rate of sperm transport through the epididymis. That work used a much lower dose of estrogen than the present study, a dose that did not affect daily sperm production. Also, the earlier studies determined the number of sperm in homogenates and not the concentration of sperm in the lumen, so they do not provide direct evidence that the estrogen treatment affected the concentration of sperm in the lumen of the cauda epididymidis. Consequently, the increased rate of sperm transport through the duct system that was observed by others could be a result of estrogen acting on the musculature of the ductus epididymidis and not be an effect of reducing fluid reabsorption by the ductuli efferentes.
This is the first report to examine how the extratesticular duct system handles intraluminal IgG and to relate this to secretions of the accessory glands of reproduction. The report is in agreement with earlier work showing that IgG can enter the rete testis, but only to achieve luminal titers that are less than 1% in blood serum [10, 46, 47]. By showing that enough IgG enters the rete testis to account for the concentrations in more distal regions of the duct system, this report is in agreement with work showing that there is no significant proluminal transport of IgG into the lumen of the ductus epididymidis [13, 48], but in disagreement with an interpretation [17] that "IgG is secreted in the epididymis and does not come from the testis." This report also shows that most IgG entering the rete testis must be reabsorbed along the duct system. This may protect against autoimmunity, because spermatogenesis commences well after immunological tolerance to self has been established [49]. The work is significant in demonstrating that there are physiological mechanisms as well as structural barriers regulating autoimmunity [8, 12]. The demonstration that Fcgrt is expressed in the extratesticular ducts is consistent with the findings of reabsorption of specific IgG mainly by the ductuli efferentes, but also by the ductus epididymidis. It is interesting to note that Fcgrt is not expressed equally along the ductus epididymidis, but this could be because the ductus is regionally specialized for functions other than the transport of IgG.
It is considered that our determinations of IgG in the reproductive fluids of the rat are representative of normal physiological conditions. There was no evidence that the use of Freund's adjuvant caused experimental autoimmune orchitis, which it does in some animals [50, 51], and which is the probable cause of infertility in guinea pigs following immunization with rPH-20 in Freund's complete adjuvant [5]. Also, the level of specific IgG in rete testis fluid is in agreement with values, relative to blood, of total IgG in rete testis fluid from animals receiving no experimental immunization [10].
The transport and maintenance of some IgG in the extratesticular ducts indicates that the system may provide some protection against sexually transmitted and other infections by the humoral as well as the cell-mediated arm of the immune system [49, 52]. However, it is doubtful that the levels of IgG that are present in the epididymal fluid and accessory gland secretions are sufficient to achieve immunocontraception in the rat following immunization with a reproductive antigen. Nevertheless, this does not exclude the chance that a vaccine can achieve some reduction in fertility in other species, such as the hamster [53], because there are interspecies differences in response to immunization with reproductive antigens. Indeed, there is a need to examine the entry of other classes of antibody into the lumen of the reproductive ducts. For example, IgA and IgM as well as IgG have been found in human and boar semen [54, 55], and in humans, prostatic fluid contains IgG [56] and the prostate gland secretes IgA [5760]. It is possible that sufficient IgA may be secreted into accessory gland fluids for this purpose so that it is worthwhile examining mucosal as well as systemic immunization to raise the immune response.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Correspondence. FAX: 61 2 4921 6923; Russell.Jones{at}newcastle.edu.au ![]()
Received: 21 February 2005.
First decision: 21 March 2005.
Accepted: 28 April 2005.
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |